Bodhi Tree Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024
Cash & Equivalents	0.05	0.11	0.26
Cash & Short-Term Investments	0.05	0.11	0.26
Cash Growth	-81.75%	-57.85%	-
Prepaid Expenses	0.02	0.01	0.01
Total Current Assets	0.07	0.12	0.27
Total Assets	0.07	0.12	0.27
Other Current Liabilities	0	-	0
Total Current Liabilities	0	-	0
Total Liabilities	0	-	0
Common Stock	0	0	0
Additional Paid-In Capital	0.33	0.33	0.33
Retained Earnings	-0.26	-0.21	-0.06
Shareholders' Equity	0.07	0.12	0.27
Total Liabilities & Equity	0.07	0.12	0.27
Net Cash (Debt)	0.05	0.11	0.26
Net Cash Growth	-81.75%	-57.85%	-
Net Cash Per Share	0.00	0.00	0.02
Filing Date Shares Outstanding	25.44	25.44	25.44
Total Common Shares Outstanding	25.44	25.44	25.44
Working Capital	0.07	0.12	0.27
Book Value Per Share	0.00	0.00	0.01
Tangible Book Value	0.07	0.12	0.27
Tangible Book Value Per Share	0.00	0.00	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.